IMDX Stock Analysis: Buy, Sell, or Hold?
IMDX - Insight Molecular Diagnostics Inc. Common Stock
$6.52
-0.10 (-1.51%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Get Alerted When IMDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IMDX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: IMDX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: IMDX is currently trading at $6.52, which is considered slightly low relative to its 30-day fair value range of $6.25 to $7.34.
Technical Outlook: Technically, IMDX is in a strong uptrend. Immediate support is located at $6.04, while resistance sits at $7.15.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $5.42. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMDX is in a strong uptrend. Immediate support is located at $6.04, while resistance sits at $7.15.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $5.42. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$6.25 -
$7.34
Company Quality Score
52/100
(HOLD)
Options IV Signal
27th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
77.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 27th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 18.2% above Wall St target ($5.42)
Fair Price Analysis
30-Day Fair Range
$6.25 -
$7.34
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$0.74
(11.4%)
Support & Resistance Levels
Support Level
$6.04
Resistance Level
$7.15
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-6.90
Wall Street Target
$5.42
(-18.2%)
Revenue Growth (YoY)
1114.8%
Last updated: January 31, 2026 12:38 AM ET
Data refreshes hourly during market hours. Next update: 1:38 AM
Data refreshes hourly during market hours. Next update: 1:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMDX showing a specific setup today?
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced IMDX Option Strategies
Professional options setups generated by AI based on today's IMDX price and gamma walls.